Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Giuliana Alimena Francesca Palandri Norbert Gattermann Hagop Kantarjian Gert J Ossenkoppele Mark R Litzow Andreas Hochhaus Francis Giles |
| Publication date | August 22, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |